Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism
- PMID: 28403947
- DOI: 10.1016/j.metabol.2017.02.003
Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism
Abstract
Objective: Berberine (BBR) clinically lowers blood lipid and glucose levels via multi-target mechanisms. One of the possible mechanisms is related to its effect on the short chain fatty acids (SCFAs) of the gut microbiota. The goal of this study is to investigate the therapeutic effect and mode of action of BBR working through SCFAs of the gut microbiota (especially, butyrate).
Methods: Gas chromatography (GC) was used to detect butyrate and other SCFAs chemically. The effect of BBR on butyrate production was investigated in vitro as well as in several animal systems. Microarrays were used to analyze the composition change in the intestinal bacteria community after treatment with BBR. BBR-induced change in the energy production and gene regulation of intestinal bacteria was examined in order to elucidate the underlying molecular mechanisms.
Results: We show that oral administration of BBR in animals promoted the gut microbiota to produce butyrate, which then enters the blood and reduces blood lipid and glucose levels. Incubating gut bacterial strains in vitro with BBR increased butyrate production. Orally treating animals directly with butyrate reduced blood lipid and glucose levels through a mechanism different from that of BBR. Intraperitoneal BBR administration did not increase butyrate but reduced blood lipid and glucose levels, suggesting that BBR has two modes of action: the direct effect of the circulated BBR and the indirect effect working through butyrate of the gut microbiota. Pre-treating animals orally with antibiotics abolished the effect of BBR on butyrate. A mechanism study showed that BBR (given orally) modified mice intestinal bacterial composition by increasing the abundance of butyrate-producing bacteria. Furthermore, BBR suppressed bacterial ATP production and NADH levels, resulting in increased butyryl-CoA and, eventually, butyrate production via upregulating phosphotransbutyrylase/butyrate kinase and butyryl-CoA:acetate-CoA transferase in bacteria.
Conclusion: Promotion of butyrate (etc) production in gut microbiota might be one of the important mechanisms of BBR in regulating energy metabolism.
Keywords: Berberine; Blood lipids and glucose; Butyrate; Gut microbiota.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Comprehensive evaluation of SCFA production in the intestinal bacteria regulated by berberine using gas-chromatography combined with polymerase chain reaction.J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Jul 1;1057:70-80. doi: 10.1016/j.jchromb.2017.05.004. Epub 2017 May 8. J Chromatogr B Analyt Technol Biomed Life Sci. 2017. PMID: 28505492
-
The gut microbiota modulator berberine ameliorates collagen-induced arthritis in rats by facilitating the generation of butyrate and adjusting the intestinal hypoxia and nitrate supply.FASEB J. 2019 Nov;33(11):12311-12323. doi: 10.1096/fj.201900425RR. Epub 2019 Aug 19. FASEB J. 2019. PMID: 31425655 Free PMC article.
-
Transforming berberine into its intestine-absorbable form by the gut microbiota.Sci Rep. 2015 Jul 15;5:12155. doi: 10.1038/srep12155. Sci Rep. 2015. PMID: 26174047 Free PMC article.
-
Berberine in the treatment of metabolism-related chronic diseases: A drug cloud (dCloud) effect to target multifactorial disorders.Pharmacol Ther. 2020 May;209:107496. doi: 10.1016/j.pharmthera.2020.107496. Epub 2020 Jan 27. Pharmacol Ther. 2020. PMID: 32001311 Review.
-
The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis?Neurochem Int. 2016 Oct;99:110-132. doi: 10.1016/j.neuint.2016.06.011. Epub 2016 Jun 23. Neurochem Int. 2016. PMID: 27346602 Review.
Cited by
-
Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut microbiota.Hepatol Commun. 2024 Mar 11;8(4):e0381. doi: 10.1097/HC9.0000000000000381. eCollection 2024 Apr 1. Hepatol Commun. 2024. PMID: 38466881 Free PMC article.
-
Prospect of research on anti-atherosclerosis effect of main components of traditional Chinese medicine Yiqi Huoxue Huatan recipe through gut microbiota: A review.Medicine (Baltimore). 2024 Feb 2;103(5):e37104. doi: 10.1097/MD.0000000000037104. Medicine (Baltimore). 2024. PMID: 38306512 Free PMC article. Review.
-
Bacteroides thetaiotaomicron ameliorates mouse hepatic steatosis through regulating gut microbial composition, gut-liver folate and unsaturated fatty acids metabolism.Gut Microbes. 2024 Jan-Dec;16(1):2304159. doi: 10.1080/19490976.2024.2304159. Epub 2024 Jan 26. Gut Microbes. 2024. PMID: 38277137 Free PMC article.
-
Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review.Front Pharmacol. 2023 Nov 15;14:1283784. doi: 10.3389/fphar.2023.1283784. eCollection 2023. Front Pharmacol. 2023. PMID: 38034996 Free PMC article. Review.
-
Systematic Myostatin Expression Screening Platform for Identification and Evaluation of Myogenesis-Related Phytogenic in Pigs.Bioengineering (Basel). 2023 Sep 22;10(10):1113. doi: 10.3390/bioengineering10101113. Bioengineering (Basel). 2023. PMID: 37892843 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
